Level C· Early human research exploring benefitsCase Report / SeriesEurope PMCOpen access

Autologous fat grafting for management of pain at spinal cord implantable pulse generator sites

Anandan SM., Sing QY., Pai AA., Misra A.

Case Report / Series with a reported sample of 4 on Back & Spine, published in JPRAS Open (2025) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Case Report / Series
Journal
JPRAS Open (2025)
Reported sample size
4
Source database
Europe PMC
PMID
40045949
PMCID
PMC11880733
DOI
10.1016/j.jpra.2024.06.019

Abstract (original English)

Implantable pulse generator site pain is prevalent in 4 to 12 percent of patients with the spinal cord stimulators. We have used a case series of 4 patients aged 46 to 79, to demonstrate pain relief at the implant site via the use of autologous fat grafting. All patients experienced an improvement of 33.3 % to 75 % in pain scores within a few weeks of the procedure. Up to a 21 month follow up date, there was still pain relief with no complications. Subsequently, we propose that autologous fat grafting may be effective and safe in pain management at the implant pulse generator sites. Further studies with larger case series and long term follow up is needed for validation.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • Without an adequate control group, treatment effects cannot be separated from other factors.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research